Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
BMRN
Stock Latest News
Ratings
BioMarin Pharmaceutical: Hold Rating Maintained Amid Competitive Pressures and New Data Insights
9d ago
BMRN
Premium
Ratings
BioMarin Pharmaceutical: Navigating Competitive Challenges with Strategic Growth Potential
9d ago
BMRN
Premium
Ratings
BioMarin Pharmaceutical’s Promising Pipeline and Strategic Focus Justify Buy Rating
21d ago
BMRN
Premium
Company Announcements
BioMarin Pharmaceutical Approves Equity Plan Amendment
28d ago
8K
BMRN
Premium
Ratings
Strategic Acquisition of Inozyme Boosts BioMarin’s Long-Term Revenue Prospects
1M ago
BMRN
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ACAD
AFMD
Premium
Ratings
Strategic Acquisition of INZY Boosts BioMarin’s Growth Potential and Pipeline Expansion
1M ago
BMRN
Premium
Ratings
BioMarin’s Strategic Acquisition of Inozyme Boosts Growth Prospects and Stock Price Target
1M ago
BMRN
Premium
Ratings
BioMarin Pharmaceutical: Balancing Opportunities and Risks Amid Inozyme Acquisition and Market Challenges
1M ago
BMRN
Premium
The Fly
Leerink bullish on BioMarin following Inozyme deal, expects additional BD
1M ago
BMRN
INZY
Premium
Ratings
BioMarin Pharmaceutical’s Strategic Growth and Market Potential: A Buy Rating by Yun Zhong
1M ago
BMRN
Premium
The Fly
BioMarin says Inozyme deal to strengthen enzyme therapies portfolio
1M ago
BMRN
INZY
Premium
Company Announcements
BioMarin Acquires Inozyme Pharma for $270 Million
1M ago
8K
BMRN
Premium
The Fly
BioMarin’s acquisition of Inozyme to strengthen enzyme therapies portfolio
1M ago
BMRN
INZY
Premium
The Fly
BioMarin to acquire Inozyme for $4.00 per share in cash, or $270M
1M ago
BMRN
INZY
Premium
The Fly
BioMarin reaffirms previously provided full-year 2025 financial guidance
1M ago
BMRN
Premium
The Fly
BioMarin reports data from studies of Voxzogo
1M ago
BMRN
Premium
Company Announcements
BioMarin Pharmaceuticals Reports Strong Q1 2025 Earnings
2M ago
BMRN
Premium
The Fly
BioMarin price target lowered to $78 from $82 at Citi
2M ago
BMRN
Premium
Ratings
BioMarin Pharmaceutical: Hold Rating Amid Strong Revenue and Cautious Outlook
2M ago
BMRN
Premium
Company Announcements
BioMarin’s Strong Q1 2025 Performance and Growth Outlook
2M ago
BMRN
Premium
Ratings
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Justify Buy Rating
2M ago
BMRN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
